Drug Discovery Conferences and Exhibitions in 2017

2 Mar 2017
Anita Ramanathan
Administrator / Office Personnel

Industry news

The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit organization bringing together academic and biopharma industry experts and thought leaders, run by the drug discovery community for the drug discovery community, announced its 2017 events program.

The series of three events throughout the year has been designed to provide a platform for stimulation of discussions on a variety of topics of interest to researchers working in early drug discovery. All events feature a program of world class science presentations from leaders in their fields, a trade show and exhibition, and poster competitions. Selected shows also have an innovation zone, aimed at showcasing the most exciting emerging life science companies. Delegate attendance at each of the events is free of charge.

Research & Innovation – Homerton College, Cambridge, 29-30 March 2017. Research & Innovation will bring together leading experts to discuss the challenges and opportunities for cells as models of disease to improve the success of drug discovery and develop new therapeutic agents.

Advances in Cell-Based Screening – AstraZeneca, Gothenburg, Sweden, 10-11 May 2017. This interactive event will host leading scientists from academia and industry to discuss the latest developments in cell-based screening in drug discovery. The meeting has been developed to cover key topics such as advanced cell models, applied omics, assays/methods exploring mode of action, phenotypic screening, target deconvolution, and much more.

Drug Discovery 2017 – ACC, Liverpool, 3-4 October 2017. ELRIG UK’s flagship event, now in its 11th year, brings together leading lights in drug discovery research across pharma, biotech, academia and the vendor community to explore innovative technologies and approaches that can be used to overcome drug development challenges.

"ELRIG UK is widely recognized as one of the UK’s most respected life science organizations, and we are committed to ensuring that our events provide highly relevant content and networking opportunities,” says Dr. Setev Rees, the Chairman of ELRIG UK. “In 2016, we saw record numbers of delegates attending our events, and our aim for 2017 is to build on that success, making our meetings accessible to an even broader audience.”

Links

Tags

High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.ExhibitionsConference
Drug Discovery Conferences and Exhibitions in 2017